Our product candidates provide opportunities to control and modify diseases, and strive to address the unmet medical needs of patients and their care partners.

Our programmes

Our liver-focused pipeline is currently built around three principal areas of high unmet need: haematology, cardiovascular and rare diseases. We also apply a patient-friendly delivery technology suitable for applications in a variety of disease settings.

silence-corporate-pipeline-diagram-2020.jpg silence-corporate-pipeline-diagram-2020.jpg